ArticleGastro hep advances2026
Neonatal and Pregnancy Outcomes in Pregnant Adults With Pediatric-Onset Crohn's Disease.
Article in Gastro hep advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Low birth weight (BW) and preterm birth are recognized complications in women with active Crohn's disease (CD). However, there is limited information on pregnancy and neonatal outcomes in patients diagnosed during childhood and adolescence. This study aims to evaluate the relationship between maternal age at CD diagnosis and pregnancy and neonatal outcomes. Methods: We conducted a retrospective, cross-sectional study of women with CD who delivered between 2012 and 2023. Gestational age (GA) at delivery and (BW) were analyzed as coprimary outcomes. Results: A total of 262 births from 179 mothers were included, with 105 (40.1%) births from women diagnosed with CD before age 18. No significant differences were observed in GA at delivery between groups. There was a significantly higher rate of neonates born small for GA to mothers with adult-onset CD compared with pediatric-onset CD (15.9% vs 3.8%, Conclusion: Neonates born to women with pediatric-onset CD have excellent outcomes including GA and BW percentiles at delivery. Longer disease duration and antitumor necrosis factor therapy were positively associated with improved BW percentiles, while disease activity had a negative impact. These findings suggest that disease control has a more significant impact on neonatal outcomes than age of onset or disease duration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.